Advarra Blog

Featured Post

The Next Generation of CIRBI, the Technology Powering Advarra’s IRB

For more than 40 years, Advarra’s institutional review board (IRB) has been built on a simple commitment: quality, clarity, and care in every review. That commitment hasn’t changed, and it never will. What does change—what has to change—is how we deliver on it. The research community moves faster every year, and the sponsors, sites, and CROs we serve deserve oversight that is as thoughtful and rigorous as it has always been, paired with the speed, expertise, and transparency that modern research demands.

Why IRBs Ask for Certified Translations of Informed Consent Forms: Regulation, Guidance, and Practical Reality 

Understanding the regulatory foundation behind translated informed consent documents and why many institutional review boards (IRBs) require…

Read more

How Integrated IRB and IBC Administration Facilitate a New Era of Interventional Genetic Therapeutics 

Gene therapies and gene-based therapeutics are giving way to a new era of interventional genetics. Integrated ethics review and…

Read more
Photo of real female scientists researching in laboratory.

The Heart’s Broken Blueprint: Rewriting the Cardiovascular Playbook with Gene Therapy 

Cardiovascular disease remains a worldwide challenge, causing undue strain on the health system and contributing substantial patient burden. For decades,…

Read more

Why Do Clinical Trial Startup Delays Still Happen Despite More Technology? 

Clinical trial study startup has become increasingly technology-enabled, yet sponsors, contract research organizations (CROs), and…

Read more

Rethinking Site Training: A Risk-based Model of Reuse and Reciprocity

Clinical trial site training is supposed to do one essential thing: Prepare site staff to…

Read more
Hands typing on a computer

How Amendment Intelligence Helps Reduce Avoidable Protocol Revisions

Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design…

Read more

Improving Clinical Trial Site Collaboration with Connected Study Startup Workflows 

Clinical trial study startup requires constant coordination across sponsors, contract research organizations (CROs), research sites,…

Read more

The Next Generation of CIRBI, the Technology Powering Advarra’s IRB

A note from Lauri Carlile, Chief Research Services Officer: For more than 40 years, Advarra’s…

Read more
Typing, medical research and man with laptop, scientist and info for biotechnology, website and lab. Healthcare, researcher and person with tech for clinical data, analysis and study for science.

21 CFR Part 11 and Good Clinical Practice Requirements Explained 

Clinical research increasingly depends on electronic systems to support core trial documentation, data handling, and…

Read more

Q&A with Advarra’s Client Services Team Lead Kyle Naylor 

Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he never…

Read more

A Practical Checklist for Building Confidence in Site Selection

How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions …

Read more

Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage 

IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight…

Read more

Looking for More?

To register for upcoming webinars and see where we’ll be next, go to the Events page.

Want to see the latest news and updates about Advarra? You can find them in the Newsroom.

Are You Ready To Bring People Together for Better, Faster Trial Outcomes?

Subscribe to our monthly email

Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.

Login
Scroll to Top